학술논문
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma
Document Type
Article
Author
Source
In Leukemia Research August 2019 83
Subject
Language
ISSN
0145-2126